Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus

Gynecologic and Obstetric Investigation

Volumn 75, Issue 3, 2013, Pages 203-209

  Kaygusuz, Ikbal ^a   Gumus, Ilknur Inegol ^a   Ylmaz, Saynur ^b   Simavli, Serap ^d   Uysal, Sema ^c   Derbent, Aysel Uysal ^e   Gözdemir, Elif ^f   Kafali, Hasan ^a  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Bolu Izzet Baysal State Hospital   (Turkey)

^e Education and Research State Hospital   (Turkey)

^f Sungurlu Hospital   (Turkey)

Author keywords

Ferritin; Gestational diabetes mellitus; Insulin resistance; Visfatin

Indexed keywords

FERRITIN; HEMOGLOBIN; INSULIN; IRON; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRANSFERRIN; GLUCOSE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEMATOCRIT; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PARITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; WEIGHT GAIN; BLOOD CHEMISTRY; CHEMICAL PARAMETERS; CLINICAL ASSESSMENT; DIAGNOSTIC TEST ACCURACY STUDY; GLUCOSE BLOOD LEVEL; IRON METABOLISM; LINEAR REGRESSION ANALYSIS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROVOCATION TEST; SERUM;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; FERRITINS; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREGNANCY;

EID: 84876784398     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000348560     Document Type: Article

References (40)

1. Fukuhara A, Matsuda M, Nishizawa M., Segawa K, Tanaka M, Kishimoto K., Matsuki Y, Murakami M, Ichisaka T., Murakami H, Watanabe E, Takagi T., Akiyoshi M, Ohtsubo T, Kihara S., Yamashita S, Makishima M, Funahashi T., Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307:426-430. (Pubitemid 40139988)
2. Sethi JK, Vidal-Puig A: Visfatin: The missing link between intra-abdominal obesity and diabetes? Trends Mol Med 2005; 11:344-347. (Pubitemid 41080573)
3. Morgan SA, Bringolf JB, Seidel ER: Visfatin expression is elevated in normal human pregnancy. Peptides 2008; 29:1382-1389.
4. Malamitsi-Puchner A., Briana DD, Boutsikou M, Kouskouni E., Hassiakos D, Gourgiotis D: Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007; 119:e1314-e1318. (Pubitemid 46871250)
5. Fasshauer M, Waldeyer T, Seeger J., Schrey S, Ebert T, Kratzsch J., Lossner U, Bluher M, Stumvoll M., Faber R, Stepan H: Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) 2008; 69:69-73. (Pubitemid 351847262)
6. Kendal-Wright C.E., Hubbard D, BryantGreenwood GD: Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor (PBEF/visfatin) expression and protects them from apoptosis. Placenta 2008; 29:255-265.
7. Haider DG, Schaller G, Kapiotis S., Maier C, Luger A, Wolzt M: The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49:1909-1914. (Pubitemid 44025046)
8. Lopez-Bermejo A., Chico-Julia B, FernándezBalsells M, Recasens M., Esteve E, Casamitjana R, Ricart W., Fernández-Real JM: Serum visfatin increases with progressive β-cell deterioration. Diabetes 2006; 55:2871-2875. (Pubitemid 44923689)
9. Chen MP, Chung FM, Chang D.M., Tsai JC, Huang HF, Shin SJ, Lee YJ: Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91:295-299. (Pubitemid 43069152)
10. Berndt J, Kloting N, Kralisch S., Kovacs P, Fasshauer M, Schon M.R., Stumvoll M., Bluher M: Plasma visfatin concentrations and fat depot-specific MRNA expression in humans. Diabetes 2005; 54:2911-2916. (Pubitemid 41401086)
11. Krzyzanowska K, Krugluger W, Mittermayer F., Rahman R, Haider D, Shnawa N., Schernthaner G: Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006; 110:605-609. (Pubitemid 43736123)
12. Ma Y, Cheng Y, Wang J., Cheng H, Zhou S, Li X: The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 2010; 90:60-65.
13. Lewandowski KC, Stojanovic N, Press M., Tuck SM, Szosland K, Bienkiewicz M, Vatish M., Lewinski A, Prelevic GM, Randeva HS: Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50:1033-1037. (Pubitemid 46559248)
14. Mazaki-Tovi S., Romero R, Kusanovic J.P., Vaisbuch E., Erez O, Than NG, Chaiworapongsa T, Nhan-Chang CL, Pacora P., Gotsch F, Yeo L, Kim S.K., Edwin SS, Hassan SS, Mittal P: Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J Perinat Med 2009; 37:218-231.
15. Chan TF, Chen YL, Lee C.H., Chou FH, Wu LC, Jong SB, Tsai EM: Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006; 13:364-367.
16. Haider DG, Handisurya A, Storka A., Vojtassakova E, Luger A, Pacini G., Tura A, Wolzt M, Kautzky-Willer A: Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007; 30: 1889-1891. (Pubitemid 47036375)
17. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28(suppl 1):S37-S42.
18. Ferrannini E: Insulin resistance, iron, and the liver. Lancet 2000; 355:2181-2182. (Pubitemid 30394321)
19. Lao TT, Chan PL, Tam KF: Gestational diabetes mellitus in the last trimester - a feature of maternal iron excess? Diabet Med 2001; 18: 218-223. (Pubitemid 32397860)
20. Scholl TO: Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005; 81:1218S-1222S. (Pubitemid 41741764)
21. Siddappa AM, Rao R, Long J.D., Widness JA, Georgieff MK: The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 2007; 92:73-82. (Pubitemid 47230732)
22. Rao R, Georgieff MK: Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med 2007; 12:54-63. (Pubitemid 46111023)
23. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat G.C., Rohan TE, Hu FB: The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2009; 1790:671-681.
24. Wilson JG, Lindquist JH, Grambow S.C., Crook ED, Maher JF: Potential role of increased iron stores in diabetes. Am J Med Sci 2003; 325:332-339. (Pubitemid 36712655)
25. Fernández-Real J.M., Ricart-Engel W, Arroyo E., Balanca R, Casamitjana-Abella R, Cabrero D, Fernández-Castaner M, Soler J: Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998; 21:62-68. (Pubitemid 28030387)
26. Fernández-Real J.M., Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 2002; 51:2348-2354. (Pubitemid 34827381)
27. McClain DA, Abraham D, Rogers J., Brady R, Gault P, Ajioka R., Kushner JP: High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 2006; 49:1661-1669. (Pubitemid 43848104)
28. Iwasaki T, Nakajima A, Yoneda M., Yamada Y, Mukasa K, Fujita K., Fujisawa N, Wada K, Terauchi Y: Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005; 28:2486-2491. (Pubitemid 41384298)
29. Chen X, Scholl TO, Stein TP: Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden Study. Diabetes Care 2006; 29:1077-1082. (Pubitemid 44115247)
30. Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144:768-773. (Pubitemid 13196587)
31. Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F., Moini A, Janani L, Mazaherioun M: Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet 2012; 285:1257-1262.
32. Klebanoff MA, Shiono PH, Selby J.V., Trachtenberg AI, Graubard BI: Anemia and spontaneous preterm birth. Am J Obstet Gynecol 1991; 164:59-63.
33. Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 1997; 20:1368-1369. (Pubitemid 27366809)
34. Lao TT, Ho LF: Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care 2004; 27:650-656. (Pubitemid 38280528)
35. Sharifi F, Ziaee A, Feizi A., Mousavinasab N, Anjomshoaa A, Mokhtari P: Serum ferritin concentration in gestational diabetes mellitus and risk of subsequent development of early postpartum diabetes mellitus. Diabetes Metab Syndr Obes 2010; 3:413-419.
36. Afkhami-Ardekani M., Rashidi M: Iron status in women with and without gestational diabetes mellitus. J Diabetes Complications 2009; 23:194-198.
37. Bo S, Menato G, Villois P., Gambino R, Cassader M, Cotrino I., Cavallo-Perin P: Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol 2009; 201: 158.e1-e6.
38. Fernández-Real J.M., Moreno JM, Chico B, Lopez-Bermejo A, Ricart W: Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007; 30:616-621. (Pubitemid 46354343)
39. Davis RJ, Corvera S, Czech MP: Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261:8708-8711. (Pubitemid 17205066)
40. Fernández-Real J.M., Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24:278-301. (Pubitemid 36724371)